Delivery Order SPE2DB24D2105-SPE2DB25FAPBJ

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,277.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Hysingla ER 60 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,819.82 firm-fixed price delivery order is for the supply of HYSINGLA ER 20 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of September 23, 2024 and does not have a set-aside designation. Amerisourcebergen has been awarded numerous contracts by DLA and other federal agencies for the...
This delivery order was awarded by the Defense Logistics Agency Troop Support Medical (DLA) to Amerisourcebergen Drug Corp for the supply of 4561791558 Hysingla ER 40 mg tablets. Under the terms of the firm fixed price contract valued at $758.22, Amerisourcebergen will deliver 60 tablets to a facility located in Conshohocken, Pennsylvania, with performance required between August 11-14, 2023. No major subcontractors or set aside designations were identified. The DLA manages the global supply...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.70, is a Delivery Order for 32mg Hydromorphone HCl Extended Release Tablets. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,477.53, is for the delivery of Hydromorphone HCL ER Tablets 12 mg, a pain medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
The U.S. government awarded a Delivery Order (DO) contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $7,832.23. The contract, with a completion date of April 17, 2023, is for the supply of Hydromorphone HCl ER Tablets 12mg to support medical needs. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,039.83 firm fixed-price contract is for the supply of hydromorphone 1 mg/ml vials, a pain management medication. The contract has an ultimate completion date of November 29, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The contract is a delivery order with a firm fixed price of $5,274.41 and an ultimate completion date of October 15, 2024. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, will be supplying this critical pain...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,731.52 Firm Fixed Price Delivery Order contract is for the supply of 4565272230 - HYDROCODONE-ACETAMN 7.5-325/15 473ML, with a period of performance through July 29, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant $999,999,999...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB25FAPBJ
    Delivery Order

This federal contract award, valued at $7,177.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hysingla ER 30 mg tablets, a medication used for pain management. This contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/4/25, 9:47 AM